Paclitaxel Protein-bound Particles For Injectable Suspension (albumin-bound)
Product Images NDC 24979-710

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Paclitaxel Protein-bound Particles For Injectable Suspension (albumin-bound) (NDC 24979-710). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Slowly Inject The 20 mL Of 0.9% Sodium Chloride Injection, Usp, Over A Minimum Of 1 Minute, Using The Sterile Syringe To Direct The Solution Flow Onto The Inside Wall Of The Vial. (Pacli 01)

An instructional diagram showing a vial connected to an intravenous (IV) infusion set. The image depicts the setup process for administering a drug from a vial using an IV line, likely representing preparation or administration of Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound).*

FDA Label Image

Structural Formula For Paclitaxel (Pacli 02)

Chemical structure of the active ingredient in Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound), as shown in the detailed molecular diagram with labeled functional groups and stereochemistry.*

FDA Label Image

Figure 1: Kaplan-meier Curve Of Overall Survival (intent-to-treat Population) (Pacli 03)

A Kaplan-Meier survival curve chart comparing the proportion of survival over time in months between two treatments: Paclitaxel protein-bound particles for injectable suspension (albumin-bound) plus Gemcitabine and Gemcitabine alone. The chart includes patient numbers at risk at multiple time points along the x-axis, with survival proportion on the y-axis.*

FDA Label Image

Principal Display Plan (100mg Vial)

Label for Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound) 100 mg per vial by Upsher-Smith Laboratories, LLC. Single-use vial indicated for intravenous use only. Includes storage instructions, administration route, and a barcode with NDC 24979-710-51.*

FDA Label Image

Principal Display Panel (100 mg Vial)

Label for Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound) 100 mg per vial, single use vial, labeled for intravenous use only. The label includes the NDC 24979-710-51 and is by Upsher-Smith Laboratories, LLC. The label features warnings against substitution and instructions to discard unused portions.*

FDA Label Image

Principal Display Panel (100 mg Vial Carton)

Packaging label for Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound) 100 mg per vial. The label includes dosage form as a sterile, lyophilized cytotoxic agent. It instructs reconstitution with 20 mL of 0.9% Sodium Chloride Injection, USP. The label warns to verify dosage and infusion rate and states the product is for intravenous use only. Manufacturer information for TWI Pharmaceuticals USA, Inc. and Abraxis BioScience, LLC is listed. The label bears multiple barcodes and the NDC 24979-710-51.*

FDA Label Image

Principal Display Panel (100 mg Vial Carton)

Packaging label for Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound) 100 mg per vial, manufactured for TWI Pharmaceuticals USA, Inc. The label includes dosing information, storage instructions, and warnings. The product is a sterile, lyophilized cytotoxic agent intended for intravenous use only. The labeler is Upsher-Smith Laboratories, LLC, with the NDC 24979-710 shown on the barcode panel.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.